Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the impact of requirements under the Human Medicines Regulations 2012 (SI 2012/1916) for prescriptions to have either a wet signature or an advanced electronic signature on the efficiency of homecare medicines services.

An assessment, through a commissioned piece of user-research of homecare paper-based prescribing, was done during the COVID-19 pandemic. NHS England will use the information in this assessment to understand the issues in homecare, as well as to inform future improvement actions, particularly developing and adoption of the Electronic Prescription Service (EPS).

No assessment has been made of the impact of requirements under the Human Medicines Regulations 2012. The only advanced electronic signature (AES) is through EPS. Not many e-prescribing systems used in secondary care have the capability to meet this AES requirement.